A S Freeman

425 total citations
15 papers, 380 citations indexed

About

A S Freeman is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, A S Freeman has authored 15 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cellular and Molecular Neuroscience, 7 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in A S Freeman's work include Neurotransmitter Receptor Influence on Behavior (8 papers), Neuroscience and Neuropharmacology Research (6 papers) and Receptor Mechanisms and Signaling (3 papers). A S Freeman is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (8 papers), Neuroscience and Neuropharmacology Research (6 papers) and Receptor Mechanisms and Signaling (3 papers). A S Freeman collaborates with scholars based in United States and China. A S Freeman's co-authors include Louis A. Chiodo, B.S. Bunney, Jing Zhang, Billy R. Martin, David K. Pitts, Claude Rouillard, Thomas G. Heffner, Leonard T. Meltzer, Curt Christoffersen and David Clark and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.

In The Last Decade

A S Freeman

15 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A S Freeman United States	9	316	165	60	47	43	15	380
R. DallʼOlio Italy	13	332 1.1×	140 0.8×	73 1.2×	36 0.8×	37 0.9×	23	406
M. Rigo Switzerland	9	313 1.0×	228 1.4×	59 1.0×	29 0.6×	37 0.9×	9	446
J. Krauss Switzerland	6	342 1.1×	215 1.3×	63 1.1×	40 0.9×	33 0.8×	10	399
Enrica Mosca Italy	10	397 1.3×	182 1.1×	63 1.1×	42 0.9×	60 1.4×	15	503
Maria G. Scrocco Italy	5	355 1.1×	181 1.1×	81 1.4×	28 0.6×	39 0.9×	6	392
M P Galloway United States	9	268 0.8×	151 0.9×	35 0.6×	62 1.3×	84 2.0×	9	373
Arsenia Scotti de Carolis Italy	10	312 1.0×	180 1.1×	60 1.0×	41 0.9×	57 1.3×	21	406
Norbert Bonhomme France	8	409 1.3×	236 1.4×	52 0.9×	71 1.5×	83 1.9×	10	524
R. IYER United States	8	319 1.0×	161 1.0×	89 1.5×	97 2.1×	41 1.0×	16	486
Maria Grabowska‐Andén Sweden	12	420 1.3×	256 1.6×	41 0.7×	42 0.9×	82 1.9×	20	548

Countries citing papers authored by A S Freeman

Since Specialization

Citations

This map shows the geographic impact of A S Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A S Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A S Freeman more than expected).

Fields of papers citing papers by A S Freeman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A S Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A S Freeman. The network helps show where A S Freeman may publish in the future.

Co-authorship network of co-authors of A S Freeman

This figure shows the co-authorship network connecting the top 25 collaborators of A S Freeman. A scholar is included among the top collaborators of A S Freeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A S Freeman. A S Freeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Drescher, Karla, A S Freeman, F.J. García-Ladona, et al.. (1997). S.21.02 Evaluation of D3 receptor antagonists. European Neuropsychopharmacology. 7. S120–S120. 9 indexed citations

Pitts, David K., et al.. (1995). Repeated stimulation of dopamine D2-like receptors: reduced responsiveness of nigrostriatal and mesoaccumbens dopamine neurons to quinpirole.. Journal of Pharmacology and Experimental Therapeutics. 275(1). 412–421. 7 indexed citations

Zhang, Jing, Louis A. Chiodo, & A S Freeman. (1994). Influence of excitatory amino acid receptor subtypes on the electrophysiological activity of dopaminergic and nondopaminergic neurons in rat substantia nigra.. Journal of Pharmacology and Experimental Therapeutics. 269(1). 313–321. 50 indexed citations

Pitts, David K., et al.. (1993). Repeated amphetamine administration: role of forebrain in reduced responsiveness of nigrostriatal dopamine neurons to dopamine agonists.. Journal of Pharmacology and Experimental Therapeutics. 264(2). 616–621. 10 indexed citations

Freeman, A S, et al.. (1991). Repeated SKF 38393 and nigrostriatal system neuronal responsiveness: functional down-regulation is followed by up-regulation after withdrawal. Naunyn-Schmiedeberg s Archives of Pharmacology. 343(5). 447–57. 7 indexed citations

Freeman, A S, et al.. (1990). Effects of (+)-4-propyl-9-hydroxynaphthoxazine on midbrain dopamine neurons: an electrophysiological study.. Journal of Pharmacology and Experimental Therapeutics. 255(1). 276–284. 5 indexed citations

Freeman, A S, et al.. (1990). Serotonergic afferent regulation of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons.. Journal of Pharmacology and Experimental Therapeutics. 253(2). 803–811. 150 indexed citations

Freeman, A S, et al.. (1989). (±)-3,4-Methylenedioxymethamphetamine-induced changes in the basal activity and pharmacological responsiveness of nigrostriatal dopamine neurons. European Journal of Pharmacology. 169(1). 11–21. 27 indexed citations

Meltzer, Leonard T., et al.. (1989). CI-943, a potential antipsychotic agent. III. Evaluation of effects on dopamine neuronal activity.. Journal of Pharmacology and Experimental Therapeutics. 251(1). 123–130. 8 indexed citations

10.

Freeman, A S, et al.. (1989). Electrophysiological characteristics and pharmacological responsiveness of midbrain dopaminergic neurons of the aged rat.. Journal of Pharmacology and Experimental Therapeutics. 249(3). 790–797. 15 indexed citations

11.

Freeman, A S & B.S. Bunney. (1987). Chronic Neuroleptic Effects on Dopamine Neuron Activity: A Model for Predicting Therapeutic Efficacy and Side Effects?. PubMed. 3. 225–235. 18 indexed citations

12.

Bunney, B.S., Louis A. Chiodo, & A S Freeman. (1985). Further Studies on the Specificity of Proglumide as a Selective Cholecystokinin Antagonist in the Central Nervous Systema. Annals of the New York Academy of Sciences. 448(1). 345–351. 37 indexed citations

13.

Clark, David, Göran Engberg, Erik Pileblad, et al.. (1984). THE EFFECTS OF NOVEL DOPAMINERGIC AGONISTS ON THE NIGROSTRIATAL DOPAMINE SYSTEM. Clinical Neuropharmacology. 7. S45–S46. 7 indexed citations

14.

Freeman, A S, et al.. (1982). Disposition of phencyclidine in mice after smoke exposure.. Drug Metabolism and Disposition. 10(6). 680–684. 6 indexed citations

15.

Freeman, A S & Billy R. Martin. (1981). Quantification of Phencyclidine in Mainstream Smoke and Identification of Phenylcyclohex-1-ene as Pyrolysis Product. Journal of Pharmaceutical Sciences. 70(9). 1002–1004. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact